Related references
Note: Only part of the references are listed.Determination of EGFR mutations in single cells microdissected from enriched lung tumor cells in peripheral blood
Ran Ran et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2013)
Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting
D. J. E. Peeters et al.
BRITISH JOURNAL OF CANCER (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
Francois-Clement Bidard et al.
CANCER AND METASTASIS REVIEWS (2013)
Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs
Francesco Fabbri et al.
CANCER LETTERS (2013)
Genomic Profiling of Isolated Circulating Tumor Cells from Metastatic Breast Cancer Patients
Mark Jesus M. Magbanua et al.
CANCER RESEARCH (2013)
Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing
Ellen Heitzer et al.
CANCER RESEARCH (2013)
Predicting therapy response in live tumor cells isolated with the flexible micro spring array device
Jean-Nicolas Gallant et al.
CELL CYCLE (2013)
Heterogeneity of Epidermal Growth Factor Receptor Status and Mutations of KRAS/PIK3CA in Circulating Tumor Cells of Patients with Colorectal Cancer
Christin Gasch et al.
CLINICAL CHEMISTRY (2013)
Circulating Tumor Cells: Liquid Biopsy of Cancer
Catherine Alix-Panabieres et al.
CLINICAL CHEMISTRY (2013)
Capture of Viable Circulating Tumor Cells in the Liver of Colorectal Cancer Patients
Eric Deneve et al.
CLINICAL CHEMISTRY (2013)
KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue
Bianca Mostert et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non-Small-Cell Lung Cancer
Emma Pailler et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
Irene Baccelli et al.
NATURE BIOTECHNOLOGY (2013)
The Efficacy of Lapatinib in Metastatic Breast Cancer with HER2 Non-Amplified Primary Tumors and EGFR Positive Circulating Tumor Cells: A Proof-Of-Concept Study
Justin Stebbing et al.
PLOS ONE (2013)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
Inertial Focusing for Tumor Antigen-Dependent and -Independent Sorting of Rare Circulating Tumor Cells
Emre Ozkumur et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis
Lixin Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer
Savitri Krishnamurthy et al.
CANCER MEDICINE (2013)
ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma
M. Ilie et al.
ANNALS OF ONCOLOGY (2012)
Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study
V. Georgoulias et al.
ANNALS OF ONCOLOGY (2012)
Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer
Mark Jesus M. Magbanua et al.
BMC CANCER (2012)
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
Tobias M. Gorges et al.
BMC CANCER (2012)
Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery
Gregory Sergeant et al.
BMC CANCER (2012)
ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer
Jeanette Dupont Jensen et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma
Mark N. Jabbour et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study
Marta Pestrin et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Multimarker Analysis of Circulating Tumor Cells in Peripheral Blood of Metastatic Breast Cancer Patients: A Step Forward in Personalized Medicine
Andreia de Albuquerque et al.
BREAST CARE (2012)
Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies
Eitan Amir et al.
CANCER TREATMENT REVIEWS (2012)
The Genetic Basis for Cancer Treatment Decisions
Janet E. Dancey et al.
CELL (2012)
Circulating tumour cells in prostate cancer patients receiving salvage radiotherapy
Lori E. Lowes et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2012)
A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers
Tsvetana Hristozova et al.
CYTOMETRY PART A (2012)
Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy
Michal Mego et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer
Naoki Hayashi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2012)
Monitoring of Circulating Tumor Cells and Their Expression of EGFR/Phospho-EGFR During Combined Radiotherapy Regimens in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Ingeborg Tinhofer et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Comparison of Next-Generation Sequencing Systems
Lin Liu et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer
Eitan Amir et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study
Kimberly L. Blackwell et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Translational Applications of Flow Cytometry in Clinical Practice
David L. Jaye et al.
JOURNAL OF IMMUNOLOGY (2012)
Opportunities and Challenges Associated with Clinical Diagnostic Genome Sequencing A Report of the Association for Molecular Pathology
Iris Schrijver et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
Considerations in the development of circulating tumor cell technology for clinical use
David R. Parkinson et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
The expanding scope of DNA sequencing
Jay Shendure et al.
NATURE BIOTECHNOLOGY (2012)
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line
Daniel C. Lazar et al.
PHYSICAL BIOLOGY (2012)
Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device
Brian J. Kirby et al.
PLOS ONE (2012)
Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines
Ashley A. Powell et al.
PLOS ONE (2012)
Molecular Characterization of Circulating Tumor Cells in Human Metastatic Colorectal Cancer
Jorge Barbazan et al.
PLOS ONE (2012)
Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer
David T. Miyamoto et al.
CANCER DISCOVERY (2012)
Biomarkers characterization of circulating tumour cells in breast cancer patients
Rosa Nadal et al.
BREAST CANCER RESEARCH (2012)
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
Sabine Kasimir-Bauer et al.
BREAST CANCER RESEARCH (2012)
Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients
Robert Koenigsberg et al.
ACTA ONCOLOGICA (2011)
Whole Cancer Genome Sequencing by Next-Generation Methods
Jeffrey S. Ross et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Should liver metastases of breast cancer be biopsied to improve treatment choice?
G. Curigliano et al.
ANNALS OF ONCOLOGY (2011)
Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology
Maureen Cronin et al.
BIOMARKERS IN MEDICINE (2011)
Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology
George Somlo et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Circulating Tumors Cells as Biomarkers Progress Toward Biomarker Qualification
Daniel C. Danila et al.
CANCER JOURNAL (2011)
Circulating tumor cells as pharmacodynamic biomarker in early clinical oncological trials
Lot A. Devriese et al.
CANCER TREATMENT REVIEWS (2011)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients
Anieta M. Sieuwerts et al.
CLINICAL CANCER RESEARCH (2011)
Molecular Characterization of Circulating Tumor Cells in Breast Cancer by a Liquid Bead Array Hybridization Assay
Athina Markou et al.
CLINICAL CHEMISTRY (2011)
DNA Methylation of Tumor Suppressor and Metastasis Suppressor Genes in Circulating Tumor Cells
Maria Chimonidou et al.
CLINICAL CHEMISTRY (2011)
Circulating Tumor Cells in Breast Cancer: Detection Systems, Molecular Characterization, and Future Challenges
Evi S. Lianidou et al.
CLINICAL CHEMISTRY (2011)
Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients
Bahriye Aktas et al.
GYNECOLOGIC ONCOLOGY (2011)
Circulating tumor cells: approaches to isolation and characterization
Min Yu et al.
JOURNAL OF CELL BIOLOGY (2011)
Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal
Angela Gradilone et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers
Andrew J. Armstrong et al.
MOLECULAR CANCER RESEARCH (2011)
HER2-Positive Circulating Tumor Cells in Breast Cancer
Michail Ignatiadis et al.
PLOS ONE (2011)
Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patients
Phillip Kim et al.
PROTEOME SCIENCE (2011)
FISH-based determination of HER2 status in circulating tumor cells isolated with the microfluidic CEE™ platform
Julie Ann Mayer et al.
CANCER GENETICS (2011)
Unravelling the complexity of metastasis - molecular understanding and targeted therapies
Nilay Sethi et al.
NATURE REVIEWS CANCER (2011)
Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases
S. J. Aitken et al.
ANNALS OF ONCOLOGY (2010)
Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells
Sabine Riethdorf et al.
TOWARD PERSONALIZED MEDICINE FOR CANCER (2010)
Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice
Dimitrios H. Roukos
BIOMARKERS IN MEDICINE (2010)
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
Tanja Fehm et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer
L. M. Flores et al.
BRITISH JOURNAL OF CANCER (2010)
Changes of HER2 Status in Circulating Tumor Cells Compared With the Primary Tumor During Treatment for Advanced Breast Cancer
Elisabetta Munzone et al.
CLINICAL BREAST CANCER (2010)
Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells
Henry K. Lin et al.
CLINICAL CANCER RESEARCH (2010)
Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
Sabine Riethdorf et al.
CLINICAL CANCER RESEARCH (2010)
Detection of Androgen Receptor Mutations in Circulating Tumor Cells in Castration-Resistant Prostate Cancer
Yuqiu Jiang et al.
CLINICAL CHEMISTRY (2010)
Detection of Circulating Tumor Cells in Breast Cancer Patients Utilizing Multiparameter Flow Cytometry and Assessment of the Prognosis of Patients in Different CTCs Levels
Yanjie Hu et al.
CYTOMETRY PART A (2010)
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study
Gini F. Fleming et al.
GYNECOLOGIC ONCOLOGY (2010)
Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer
Kimberly L. Blackwell et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
APPLICATIONS OF NEXT-GENERATION SEQUENCING Sequencing technologies - the next generation
Michael L. Metzker
NATURE REVIEWS GENETICS (2010)
Circulating tumour cells in clinical practice: Methods of detection and possible characterization
Marianna Alunni-Fabbroni et al.
METHODS (2010)
Molecular Biomarker Analyses Using Circulating Tumor Cells
Elizabeth A. Punnoose et al.
PLOS ONE (2010)
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
Shannon L. Stott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience
D. Olmos et al.
ANNALS OF ONCOLOGY (2009)
Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR
Anieta M. Sieuwerts et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients
Marta Pestrin et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer
Pamela L. Paris et al.
CANCER LETTERS (2009)
Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard et al.
CANCER RESEARCH (2009)
Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancer
Bianca Mostert et al.
CANCER TREATMENT REVIEWS (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer
Margaret A. Leversha et al.
CLINICAL CANCER RESEARCH (2009)
Next-Generation Sequencing: From Basic Research to Diagnostics
Karl V. Voelkerding et al.
CLINICAL CHEMISTRY (2009)
Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detection
Lili Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer
Catherine Alix-Panabieres et al.
BREAST CANCER RESEARCH (2009)
Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells
Tanja Fehm et al.
BREAST CANCER RESEARCH (2009)
Detection of TMPRSS2:ERG fusion gene in circulating prostate cancer cells
Xueying Mao et al.
ASIAN JOURNAL OF ANDROLOGY (2008)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Clinical Utility of Microarrays: Current Status, Existing Challenges and Future Outlook
Xinmin Li et al.
CURRENT GENOMICS (2008)
Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis
Jing Yang et al.
DEVELOPMENTAL CELL (2008)
Expression of BRCAI protein in breast cancer and its prognostic significance
Emad A. Rakha et al.
HUMAN PATHOLOGY (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Next-generation DNA sequencing
Jay Shendure et al.
NATURE BIOTECHNOLOGY (2008)
Detection of mutations in EGFR in circulating lung-cancer cells
Shyamala Maheswaran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Detection, clinical relevance and specific biological properties of disseminating tumour cells
Klaus Pantel et al.
NATURE REVIEWS CANCER (2008)
The potential role of Akt phosphorylation in human cancers
J. Cicenas
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2008)
Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients
Galatea Kallergi et al.
BREAST CANCER RESEARCH (2008)
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath et al.
NATURE (2007)
Circulating tumour cell detection on its way to routine diagnostic implementation?
Stefan Sleijfer et al.
EUROPEAN JOURNAL OF CANCER (2007)
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
M. Yoshimoto et al.
BRITISH JOURNAL OF CANCER (2007)
Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice
Clifford A. Hudis
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer
David R. Shaffer et al.
CLINICAL CANCER RESEARCH (2007)
Statistical considerations for enumeration of circulating tumor cells
Arjan G. J. Tibbe et al.
CYTOMETRY PART A (2007)
HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases:: a possible tool for anti-HER2 therapy management?
A. Vincent-Salomon et al.
BRITISH JOURNAL OF CANCER (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
Tanja Fehm et al.
BREAST CANCER RESEARCH (2007)
uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues
Songdong Meng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Circulating tumor cells versus imaging - Predicting overall survival in metastatic breast cancer
G. Thomas Budd et al.
CLINICAL CANCER RESEARCH (2006)
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
Marc Buyse et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease
J Zidan et al.
BRITISH JOURNAL OF CANCER (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Change of HER-2/neu status in a subset of distant metastases from breast carcinomas
P Regitnig et al.
JOURNAL OF PATHOLOGY (2004)
The assessment of PTEN tumor suppressor gene in combination with Gleason scoring and serum PSA to evaluate progression of prostate carcinoma
IT Koksal et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2004)
HER-2 gene amplification can be acquired as breast cancer progresses
SD Meng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
HER2 expression in breast cancer primary tumours and corresponding metastases.: Original data and literature review
J Carlsson et al.
BRITISH JOURNAL OF CANCER (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: A phase II trial of the Gynecologic Oncology Group
MA Bookman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Dissemination and growth of cancer cells in metastatic sites
AF Chambers et al.
NATURE REVIEWS CANCER (2002)
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites
D Gancberg et al.
ANNALS OF ONCOLOGY (2002)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
First-line, single-agent Herceptin (R) (trastuzumab) in metastatic breast cancer: a preliminary report
C Vogel et al.
EUROPEAN JOURNAL OF CANCER (2001)
Share Paper
